Ironshore Pharmaceuticals Inc.
Ironshore Pharmaceuticals Inc. is a pharmaceutical company whose mission is to develop innovative, patient-centric treatment options using the proprietary DELEXIS® drug delivery technology to improve the lives of patients and caregivers. Ironshore is a leader in the research, development and commercialization of novel treatment options for Attention Deficit Hyperactivity Disorder (ADHD) which leverage this unique technology.